Biomedical Engineering Reference
In-Depth Information
Bertholon, I., Lesieur, S., Labarre, D., Besnard, M., and Vauthier C. 2006b. Characterization of dextran-
poly(isobutylcyanoacrylate) copolymers obtained by redox radical and anionic emulsion polymerization.
Macromolecules
. 39:3559-67.
Bertholon, I., Hommel, H., Labarre, D., and Vauthier, C. 2006c. Properties of polysaccharides grafted on
nanoparticles investigated by EPR.
Langmuir
. 22:5485-90.
Bravo-Osuna, I., Vauthier, C., Farabollini, A., Palmieri, G.F., and Ponchel, G. 2007. Mucoadhesion mechanism
of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles.
Biomaterials.
28:2233-43.
Chauvierre, C., Labarre, D., Couvreur, P., and Vauthier, C. 2003. Novel polysaccharide-decorated poly(isobutyl
cyanoacrylate) nanoparticles.
Pharm. Res.
20:1786-93.
Chauvierre, C., Vauthier, C., Labarre, D., and Hommel, H. 2004. Evaluation of the surface properties of dex-
tran coated poly(isobutylcyanocrylate) nanoparticles by spin-labelling coupled with electron resonance
spectroscopy.
Coll. Polym. Sci.
282:1016-25.
Couvreur, P. and Vauthier, C. 2006. Nanotechnology: Intelligent design to treat complex disease
. Pharm. Res.
23:1417-50.
Daniel, J.C. 2003. A long history with many future challenges to meet in the future—Free-radical emulsion
polymerization and aqueous polymer dispersions. In:
Colloidal Polymers, Synthesis and Characterisation,
Surfactant Science Series
. Ed. A. Elaissari, 115:1-22. New York: Marcel Dekker.
de Martimprey, H., Vauthier, C., Malvy, C., and Couvreur, P. 2009. Polymer nanocarriers for the deliv-
ery of small fragments of nucleic acids: Oligonucleotides and siRNA.
Eur. J. Pharm. Biopharm
.
71(3):490-504.
Dobrovolskaia, M.A., Aggarwal, P., Hall, J.B., and McNeil, S.E. 2008. Preclinical studies to understand
nanoparticle interaction with the immune system and its potential effects on nanoparticle biodistribution.
Mol. Pharm.
5:487-95.
Douglas, S.J., Illum, L., Davis, S.S., and Kreuter, J. 1984. Particle size and size distribution of poly(butyl 2
cyanoacrylate) nanoparticles. Influence of physicochemical factors.
J. Coll. Interface Sci.
101:149-158.
Etheridge, M.L., Campbell, S.A., Erdman, A.G., Haynes, C.L., Wolf, S.M., and McCullough, J. 2013.
The big picture on nanomedicine: The state of investigational and approved nanomedicine products.
Nanomedicine:NBM
. 9:1-14.
Estephan, Z.G., Jaber, J.A., and Schlenoff, J.B. 2010, Zwitterion-stabilized silica nanoparticles: Toward non-
stick nano.
Langmuir
. 26:16884-9.
Farokhzad, O.C. and Langer, R. 2009. Impact of nanotechnology on drug delivery.
ACS Nano
. 1:16-20.
Gref, R., Lück, M., Quellec, P., Marchand, M., Dellacherie, E., Harnisch, S. et al. 2000. Stealth corona-core
nanoparticles surface modified by polyethylene glycol (PEG): Influences of the corona (PEG chain
length and surface density) and of the core composition on phagocytic uptake and plasma protein adsorp-
tion.
Colloids Surf B Biointerfaces.
18:301-13.
Gref, R., Minamitake, Y., Peracchia, M.T., Domb, A., Trubetskoy, V., Torchilin, V. et al. 1997. Poly(ethylene
glycol)-coated nanospheres: Potential carriers for intravenous drug administration.
Pharm. Biotechnol.
10:167-98.
Gref, R., Minamitake, Y., Peracchia, M.T., Trubetskoy, V., Torchilin, V., and Langer, R. 1994
.
Biodegradable
long-circulating polymeric nanospheres. Science 263:1600-3.
Gregoriadis, G. 1976. The carrier potential of liposomes in biology and medicine.
N. Eng. J. Med.
295:704-10.
Gregoriadis, G., Wills, E.J., Swain, C.P., and Tavill, A.S. 1974. Drug-carrier potential of liposomes in cancer
chemotherapy.
Lancet
. 1:1313-6.
Hirsh, S.L., McKenzie, D.R., Nosworthy, N.J., Denman, J.A., Sezerman, O.U., and Bilek, M.M.M. 2013. The
Vroman effect: Competitive protein exchange with dynamic multilayer protein aggregates.
Coll. Surf. B:
Biointerfaces
103:395-404.
Jeon, S.I. and Andrade, J.D. 1991. Protein-surface interactions in the presence of polyethylene oxide: II. Effect
of protein size.
J. Coll. Interf. Sci.
142:159-166.
Jeon, S.I., Lee, J.H., Andrade, J.D., and De Gennes P.G. 1991. Protein-surface interactions in the presence of
polyethylene oxide: I. Simplified theory.
J. Coll. Interf. Sci.
142:149-158.
Jiskoot, W., Van Schie, R.M.F., Carstens, M.G., and Schellekens, H. 2009. Immunological risk of injectable
drug delivery systems.
Pharm. Res.
26:1303-14.
Juliano, R.L. 1976. The role of drug delivery systems in cancer chemotherapy.
Prog. Clin. Biol. Res.
9:21-32.
Kreuter, J. 2007. Nanoparticles—A historical perspective.
Int. J. Pharm.
331:1-10.
Kreuter, J. and Speiser, P.P. 1976. New adjuvants on a polymethylmethacrylate base.
Infect. Immun
. 13,
204-210.
